Connect with us

Health Tech

Reinforcing medication adherence with affordability  

By William J. Febbo, CEO At OptimizeRx

TechCEO

Published

on

William J. Febbo

Reinforcing medication adherence with affordability

Even if hospitals and physicians do everything right, treatments falter when patients don’t take the prescribed medications. Inability to afford medications is the major reason for non-adherence. Many patients don’t take advantage of prescription discounts just because they don’t know about them.

“Billions of dollars in coupons and vouchers from pharmaceutical manufacturers go unused because physicians and patients simply lack knowledge of and access to these offerings.” says William J. Febbo, the CEO of OptimizeRx.

This is where OptimizeRx® comes in.  OptimizeRx’s platform integrates into EHRs and automatically provides prescription copay information at the point-of-prescribe, thus allowing providers and patients access to available discounts when it matters most.

The OptimizeRx platform extends beyond the point-of-care. Its patient engagement module further improves the likelihood of treatment plan follow-through. Despite a complex healthcare ecosystem, the platform enhances connections between pharma, providers, patients, and payers.

The Journey

Febbo founded with his physician brother a pharmaceutical-based market research company where he learned a lot about bringing together industry and medical professionals. He sold the company in 2006, bought it back in 2009 and sold it again in 2015. This exposed him to public markets, raising capital and the health technology solutions with medical and pharma stakeholders. The diverse exposure helped him learn to manage growth as well as expectations – ultimately leading to his role at OptimizeRx, an early stage public company.

Febbo was not an OptimizeRx founder, but the company has witnessed incredible growth since he joined. Three years ago, OptimizeRx was a software company with 10 employees and three interns. Since then, valuation has gone from a low of $27M to $230M, from no analyst coverage to 4 analysts, and from OTC to Nasdaq. Febbo’s passion to connect the pharma industry with medical professionals drove the team to transform an existing software company into a health-tech enterprise that improves care, adherence, and affordability, which now impacts tens of millions of patients.

I’ve learned as a leader, you cannot control timing, so it’s all about surrounding yourself with the right people. It’s not about me being the smartest person in the room -it’s about working with others who know the industry inside and out.

Do Big Things

Despite rapid changes in the digital health landscape, the industry continues to lag behind and costs continue to rise. Healthcare providers are expected to offer better care while experiencing a shift to electronic systems – often spending 5-6 hours a day within the EHR. The vision to incorporate the financial and formulary information providers may need within their EHR seemed impossible. Despite regulations and innovations in the last decade, disparate systems continue to lack significant connectivity.  OptimizeRx’s platform and underlying network of EHRs continues to grow and evolve to find more ways to engage patients and providers across the care continuum without expanding the efforts of the physician.

According to Febbo, to solve a significant problem like this you have to be open to experimenting and willing to risk some efficacy. Innovation and risk are the two sides of the same coin. You have to focus on your end goal without being distracted by naysayers and take criticism positively. “Do not yield to those in the industry who say, “It can’t happen.” Use it to push you and keep going full speed”, he suggests.

Rethinking Failure

“It is OK to look at “microfails” and perhaps consider what each misstep can teach us about the next risk we’re willing to take. That said, if you fail to fail, you can’t succeed. So, it’s also OK to aim high!”, advises Febbo.

We couldn’t agree more because revolutionary changes don’t happen overnight. A willingness to experiment and the wisdom to learn from mistakes are keys to success. After all, what got you here won’t ever get you there.

Advice for the Booming Entrepreneurs

Febbo encourages budding entrepreneurs to take risks. He also advises them to focus on making an actual impact rather than just focusing on the numbers.

“I’d remind those early on in their careers to always see the bottom line—not necessarily the bottom-line from a numbers-perspective, but on doing work that will actually have an impact.”

William J. Febbo

Company: OptimizeRx

Website: www.optimizerx.com

Management: William J. Febbo, CEO & Director

Founded Year: 2006

Headquarters: Rochester, MI

Description: provides unique physician and consumer platforms and strategies to help patients better afford and adhere to their treatment regimens, while offering pharmaceutical and healthcare companies more effective ways to deliver relevant information and services to healthcare providers and their patients right at the point of care.

Top 50 Healthcare Technology CEOs Of 2020

HealthTech

Continue Reading

Health Tech

AI to help kids struggling with ADHD, PDD-NOS and other ASD’s  

By Stephane Bourles, CIO at Brain Balance

TechCEO

Published

on

AI to help kids struggling with ADHD, Autism, Asperger Syndrome , PDD-NOS and other ASD’s

Left Brain or Right Brain?

In a properly functioning brain, both hemispheres communicate equally and at lightning speed, millions of times per minute. In a poorly functioning brain, the left and right sides of the brain only impart partial information, causing frequent miscommunication. This is called Functional Disconnection and is the root of many types of learning, behavioral and social problems found in children. The Brain Balance program puts the left and right brains back in sync using sensory motor exercises, academic skill building, and nutrition guidelines.

How does the Assessment Work?

The assessment consists of sensory, motor, and academic testing of more than 900 functions. The outcome of this assessment is a highly customized report providing parents with a complete understanding of their child’s behavioral, social, and academic skill levels.

We use AI to determine which brain hemisphere we believe to be stronger or weaker. The Machine Learning algorithm used for the assessment is not always accurate, which we know based on the feedback from our staff—yes we let them disagree with the system, which is intended as a tool to help them support their own assessment, but not to necessarily force them into a decision they don’t agree with.
But as valuable as an individual observation based on years of experience is, it still remains just the view of one individual. That is why we look at Artificial Intelligence as a new solution combining neural network architectures with massive computing power to enable our solution to learn a pattern from large datasets and make statistical predictions based on test results and feedback we already have for tens of thousands of students.

What is next?

Thanks to many product releases with different Machine Learning models we tested, we were able to improve our assessment accuracy and achieve precision, recall and F1 scores over 0.95. The limitation of this AI model is it is not 100% accurate and you don’t know for sure the source of truth. Since AI is a “black box” which can’t explain its prediction for most models, you have to trust your staff first.

Similar to clinical decision support systems helping healthcare practitioners, we believe this fast growing dataset about children, combined with new Artificial Intelligence models such as Explainable AI, will help our staff improve a child’s initial assessment, which will then improve our overall program’s results.

Continue Reading

Health Tech

The importance of information to empower health-app users  

By Liz Ashall-Payne, CEO, ORCHA

TechCEO

Published

on

Shining a light between the rock and the hard place: The importance of information to empower health-app users

Apps, and their use for the promotion of health and wellbeing, are the subject of increasing interest and enquiry; particularly in light of the NHS’ Long Term Plan, and ever-increasing pressures on scarce NHS resources. But finding and downloading effective, engaging, and most importantly, safe health-apps, is a significant challenge. While many have suggested that health-apps could be a ‘silver-bullet’, aimed at quashing the woes that stem from decreasing funding and increasing demand for incumbent NHS services, it is important to tread with caution.

Unlike pharmaceuticals, over the counter remedies, talking therapies, physiotherapy or surgery, health-apps can not only be sought, but readily obtained in absence of gatekeeping and safeguarding. The result is that you or I can download upwards of 200,000 health-apps today, with as little as a click of a button on the app-store. While this can be argued as the unique value-proposition of app-based health technologies, a lack of guarantees regarding the quality and content of such apps, means that this open-access feature of apps also represents the chief concern; and is likely limiting the enthusiasm with which healthcare professionals engage and promote their use.

The number of apps labelled as ‘pranks’ or for ‘illustration purposes only’ has been subject to year-on-year growth. But for those looking for convenient, easily accessible, and often cost-free support; or for those who are either vulnerable or impressionable; such technologies can pose significant health risks, beyond those that are apparent and conveyed (if at all) in the short description within the app store. An app that misleadingly claims to monitor blood pressure or blood sugar for example, may result in either (1) misleading information, (2) modifications to disease management not representative of true disease status (including the use of insulin or warfarin), or (3) serious adverse events including hypoglycaemia or stroke. One such app for monitoring blood pressure has been downloaded upwards of 1,000,000 times on the Android Google Play app store, while boasting a review rating of 4.3/5.

This raises questions regarding the utility of both the subjective user review score (which is inherently limited in only capturing both very positive or very negative views) and the number of prior downloads of an app, as potential surrogates for app quality. Recent research into apps targeted at chronic insomnia disorder conducted by the Organisation for the Review of Care and Health Applications (ORCHA) confirmed this. In this analysis, which is now available in the journal BMJ: Evidence-Based Mental Health, it was demonstrated that both user review scores, and the number of prior downloads of a health-app, were not only unreliable as proxies for quality, but in fact were inversely related; and as these metrics increased, the objectively measured quality of apps decreased (as assessed by presence of clinical evidence, data privacy policies etc.) This has left a considerable void regarding where reliable indicators of the safety and quality of app-based health technologies can be found, something which at least in part, has been tackled by the National Health Service (NHS).

Courtesy of the NHS’s digital assessment questionnaire (DAQ), and the NHS apps library (beta version), the number of ‘accredited’ and NHS-approved health-apps is increasing, albeit at a leisurely pace, with approximately 50 apps accredited so far. While a step in the right direction, the rigour with which such reviews are conducted comes at the expense of speed, and an estimated review time of 6-8 weeks, limits the possibility of such initiatives being conducted at scale. As such, the difference between the total number of health-apps available (~300,000), and those which have been quality-tested and approved by regulators or accreditation bodies (~50); is if anything, increasing; leaving little or no information regarding the validity, efficacy, and most importantly the safety, of 99.99% of health-apps available today; which to date have been downloaded by potential users upwards of 50million times.

This is where the Organisation for the Review of Care and Health Applications (ORCHA) aim to transform the process of health-app research and information provision. Positioned as an open-access, free of charge and publicly facing repository regarding the user experience, clinical efficacy, and data privacy of thousands of health-apps, ORCHA’s aim is simple; to empower and inform potential users of health-apps regarding potential risks and benefits, prior to committing to use. Through a structured, objective and peer-reviewed assessment, consisting of 160 question areas, answered on a ‘yes’ or ‘no’ basis, ORCHA provides information to the 99% of users of health-apps, which are yet to be formally assessed by health technology assessment bodies, and in doing so, ORCHA removes the information asymmetry that is currently clouding the health-app market in, distrust, disbelief, and uncertainty. Publishing a new review of a health-app every 30minutes on average, ORCHA pull in information for all 300,000+ apps available on both iOS and Android Google Play, organise these into medically approved sub-categories (including diabetes, mental health and diet and exercise), and then order these apps from the most to the least downloaded.

In doing so, ORCHA believe that focusing attention on providing information about the risks and benefits of apps currently used the most, and those which others are most likely to download, is likely to have the largest overall impact on the safety and effectiveness with which such apps are used. By providing a short, sharp summary of each app, prior to download, highlighting concerns including the lack of a data privacy policy, a lack of evidence to support claims of effectiveness, or a lack of accessibility options for those who are hard of sight or hearing for example; ORCHA is providing information regarding the ‘many’ health apps currently in use, and eliminating the information uncertainty that not only limits the allure of health-apps, but also puts users at risk when unknowingly using health-apps which do not look after your data, and may cause physical harm if used in the belief that they are approved medical technologies.

Continue Reading

Health Tech

Barbara Howard, MD to Receive the 2019 C. Anderson Aldrich Award  

By Karen Gauthier Sales & Marketing Coordinator, Total Child Health

TechCEO

Published

on

August 20, 2019

The American Academy of Pediatrics (AAP) Section on Developmental and Behavioral Pediatrics announced that Barbara Howard, MD will receive the 2019 C. Anderson Aldrich Award.

The C. Anderson Aldrich Award is bestowed by the Section on Developmental and Behavioral Pediatrics of the American Academy of Pediatrics to honor professionals who have made outstanding contributions to the field of child development. Its earlier recipients include some of the world’s most famous pediatricians, such as Benjamin Spock and T. Berry Brazelton; child psychiatrists, such as Anna Freud, and Sir Michael Llewellyn Rutter and child psychologists, such as Erik Erickson.

Howard is a Developmental-Behavioral Pediatrician who trained with Dr. T. Berry Brazelton at Harvard University.  Dr. Howard is probably the most popular and beloved teacher and recognized care innovator of developmental and behavioral aspects of pediatrics in the United States.  She has been a frequently invited national speaker over the past several decades and at one point was noted by the AAP as the highest-rated speaker of any specialty in pediatrics.

Pediatricians also have had access to her wisdom about practical approaches to developmental and behavioral aspects of pediatrics through a regular column in the free Pediatric News over the past two decades.  Many pediatricians have attended the free monthly case conferences through a federal grant she has had continuously for thirty years, first in person and in recent years as a national webcast.  Pediatric residents at Hopkins, Duke, Sinai, and U Mass have benefited and she also co-directed a fellowship program to train developmental and behavioral pediatricians as a faculty member at Johns Hopkins, where she continues a faculty role.

In recent years, Barbara has used an innovative online “clinical process support system”, called CHADIS to provide “moment of care” education to pediatricians specifically related to their own patients via pre-visit questionnaires, reaching 3,000 pediatricians for over 2 million of their patients.

Dr. Howard was past President of the Society for Developmental and Behavioral Pediatrics. She was a contributing author for Bright Futures™, Diagnostic and Statistical Manual for Primary Care (DSM-PC) and Bright Futures in Practice: Mental Health and has served on national committees of the American Academy of Pediatrics.  Dr. Howard has also made contributions by leading thirteen NIH and CDC funded research programs in areas such as autism, ADHD, asthma, infant mental health and current grants for Social Determinants of Health, teen depression and substance use prevention.  These research programs have made contributions to the literature and also evidence to support modules in CHADIS that continue to teach and guide pediatricians family medicine doctors and now branching out to mental health providers and adult medicine.

Howard will receive the award during the 2019 AAP National Conference & Exhibition in New Orleans, LA on Saturday, October 26, 2019.

The mission of Total Child Health, Inc. is to provide products and services that improve mental and physical health. In particular, the company focuses on the development and distribution of CHADIS (CHADIS.com).

Continue Reading
Show Buttons
Hide Buttons